BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening Initiative
BD (NYSE: BDX) has launched the Love Your Limbs™ PAD Community Screening Initiative to combat Peripheral Artery Disease (PAD), a circulatory disorder affecting over 21 million Americans and 200 million people globally. The initiative offers free ankle-brachial index screenings in partnership with physicians to detect PAD early.
The company is developing a PAD Health Access Dashboard and Heatmap to identify high-need communities and is partnering with organizations like Ochsner Health and The Way to My Heart. BD is also supporting the American Heart Association's National PAD Action Plan to increase awareness and improve early diagnosis of PAD, which causes over 150,000 preventable amputations annually in the U.S.
BD (NYSE: BDX) ha avviato l'iniziativa Love Your Limbs™ PAD Community Screening Initiative per contrastare la malattia delle arterie periferiche (PAD), un disturbo circolatorio che colpisce oltre 21 milioni di americani e 200 milioni di persone nel mondo. L'iniziativa offre, in collaborazione con medici, screening gratuiti tramite indice caviglia-braccio per individuare precocemente la PAD.
L'azienda sta sviluppando una PAD Health Access Dashboard e una Heatmap per localizzare le comunità con maggior bisogno e collabora con realtà come Ochsner Health e The Way to My Heart. BD sostiene inoltre il National PAD Action Plan dell'American Heart Association per aumentare la consapevolezza e migliorare la diagnosi precoce della PAD, che causa oltre 150.000 amputazioni prevenibili ogni anno negli Stati Uniti.
BD (NYSE: BDX) ha lanzado la iniciativa Love Your Limbs™ PAD Community Screening Initiative para combatir la enfermedad arterial periférica (PAD), un trastorno circulatorio que afecta a más de 21 millones de estadounidenses y a 200 millones de personas en todo el mundo. La iniciativa ofrece exámenes gratuitos del índice tobillo-brazo en colaboración con médicos para detectar la PAD de forma temprana.
La compañía está desarrollando un PAD Health Access Dashboard y un mapa de calor para identificar comunidades con alta necesidad, y se asocia con organizaciones como Ochsner Health y The Way to My Heart. BD también apoya el National PAD Action Plan de la American Heart Association para aumentar la concienciación y mejorar el diagnóstico precoz de la PAD, que provoca más de 150.000 amputaciones prevenibles anualmente en EE. UU.
BD (NYSE: BDX)는 말초동맥질환(PAD)에 대응하기 위해 Love Your Limbs™ PAD Community Screening Initiative를 출범했습니다. PAD는 순환계 질환으로 미국에서 2,100만 명, 전 세계적으로 2억 명 이상에게 영향을 미칩니다. 이 프로그램은 의사들과 협력해 발목-상완 지수(ABI) 무료 검진을 제공해 PAD를 조기에 발견하도록 돕습니다.
회사는 PAD Health Access Dashboard와 히트맵을 개발해 지원이 필요한 지역을 파악하고 있으며 Ochsner Health, The Way to My Heart 같은 단체들과 협력하고 있습니다. 또한 BD는 미국심장협회(American Heart Association)의 National PAD Action Plan을 지원해 인식을 높이고 PAD의 조기 진단을 개선하려 하고 있으며, PAD는 미국에서 연간 15만 건 이상의 예방 가능한 절단을 유발합니다.
BD (NYSE: BDX) a lancé l'initiative Love Your Limbs™ PAD Community Screening Initiative pour lutter contre l'artériopathie périphérique (PAD), un trouble circulatoire qui touche plus de 21 millions d'Américains et 200 millions de personnes dans le monde. L'initiative propose, en partenariat avec des médecins, des dépistages gratuits par indice cheville-bras pour détecter précocement la PAD.
L'entreprise développe un PAD Health Access Dashboard et une carte thermique pour repérer les communautés à fort besoin et s'associe à des organisations telles que Ochsner Health et The Way to My Heart. BD soutient également le National PAD Action Plan de l'American Heart Association afin d'accroître la sensibilisation et d'améliorer le diagnostic précoce de la PAD, qui entraîne aux États-Unis plus de 150 000 amputations évitables par an.
BD (NYSE: BDX) hat die Love Your Limbs™ PAD Community Screening Initiative gestartet, um periphere Arterienerkrankung (PAD) zu bekämpfen – eine Durchblutungsstörung, die mehr als 21 Millionen Amerikaner und weltweit 200 Millionen Menschen betrifft. Die Initiative bietet in Zusammenarbeit mit Ärzten kostenlose Knöchel-Arm-Index-Screenings zur Früherkennung von PAD an.
Das Unternehmen entwickelt ein PAD Health Access Dashboard und eine Heatmap, um besonders bedürftige Gemeinden zu identifizieren, und arbeitet mit Organisationen wie Ochsner Health und The Way to My Heart zusammen. BD unterstützt außerdem den National PAD Action Plan der American Heart Association, um das Bewusstsein zu steigern und die frühe Diagnose von PAD zu verbessern, die in den USA jährlich über 150.000 vermeidbare Amputationen verursacht.
- Initiative provides free PAD screenings to underserved communities
- Development of data-driven PAD Health Access Dashboard to identify high-risk areas
- Strategic partnerships with healthcare providers and nonprofits to expand reach
- None.
PAD affects more than 21 million Americans1 and more than 200 million people globally.2 Without early diagnosis and intervention, PAD can lead to stroke, heart attack and limb loss.3 More than 150,000 preventable amputations occur annually in the
Breaking Barriers Through the Love Your Limbs™ PAD Community Screening Initiative
As part of the BD commitment to PAD awareness, the company launched the Love Your Limbs™ PAD Community Screening Initiative to expand access to PAD screening by partnering with physicians to offer free ankle-brachial index (ABI) screenings, which are essential, non-invasive test that can detect PAD in less than 15 minutes.6
"Too many lives are lost or forever changed because PAD is diagnosed too late—or not at all," said Rob Righi, vice president and general manager of the Vascular Platform at BD Peripheral Intervention. "With Love Your Limbs™, we're breaking barriers to detection and care by meeting patients where they are and building bridges between communities, providers and the healthcare system."
In June, BD supported a series of community screenings, partnering with Ochsner Health for the 4th Annual Men's Health Event in
Using Data and Partnerships to Reduce Care Disparities
To help guide future outreach and prioritize high-need communities, the BD Center of Excellence for Health Economics and Outcomes Research is developing a PAD Health Access Dashboard and Heatmap. This interactive data-driven application is designed to quickly identify geographies with high amputation rates to help target interventions where they can have the most impact.
The American Heart Association's National PAD Action Plan, sponsored in part by BD, is a coordinated campaign aimed at increasing public awareness, improving early diagnosis and enhancing quality of life for those living with PAD. This collaborative effort reflects BD's belief in the power of united action to reduce preventable PAD-related complications.
Together, We Can Save Limbs and Lives
PAD is often called a "silent threat"- up to
With timely screening, treatment and education, most PAD-related complications can be avoided. With a long-standing legacy of vascular innovation, BD continues to deliver tools and technologies that empower clinicians to diagnose and treat PAD earlier and more effectively. From devices that restore blood flow to educational programs that advance evidence-based care, BD is committed to driving better outcomes for patients living with PAD.
This PAD Awareness Month, BD urges healthcare providers, community leaders and individuals to join the movement to raise awareness, promote early detection and advocate for life- and limb-saving care.
To learn more or get involved, visit https://loveyourlimbs.com.
About BD
BD is one of the largest global medical technology companies in the world and is Advancing the World of Health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts:
Media: | Investors: |
Fallon McLoughlin | Adam Reiffe |
Director, Public Relations | Sr. Director, Investor Relations |
201.258.0361 | 201.847.6927 |
1 Yost M. The current
2 Allison MA, Armstrong DG, Goodney PP, et al. Health disparities in peripheral artery disease: A scientific statement from the American Heart Association. Circulation. 2023;148(3):286-296. doi:10.1161/CIR.0000000000001153
Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, McDermott MM, Misra S, Ujueta F. Lower Extremity Peripheral Artery Disease:
3 Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, McDermott MM, Misra S, Ujueta F. Lower Extremity Peripheral Artery Disease:
Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association. Circulation. 2021;144(9):e171–e191.
4 Creager MA, Matsushita K, Arya S, Beckman JA, Duval S, Goodney PP, Gutierrez JAT, Kaufman JA, Joynt Maddox KE, Pollak AW, Pradhan AD,
Whitsel LP. Reducing Nontraumatic Lower-Extremity Amputations by
9 Gornik HL, Aronow HD, Goodney PP, et al. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(24):e1313-e1410. doi:10.1161/CIR.0000000000001251
View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-expands-peripheral-artery-disease-awareness-efforts-with-love-your-limbs-community-screening-initiative-302543548.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
What is BD's Love Your Limbs PAD Community Screening Initiative?
How many people are affected by PAD according to BD (NYSE: BDX)?
What partnerships has BD formed for PAD awareness?
How many preventable amputations occur annually in the US due to PAD?
What percentage of individuals with PAD experience no symptoms?
